发明名称 Liquid pharmaceutical composition for the treatment of a posterior eye disease
摘要 The invention provides pharmaceutical compositions based on liquid vehicles whose density is substantially higher than that of aqueous physiological fluids. The compositions are useful as medicines in ophthalmology, in particular for the treatment of conditions affecting the posterior segment of an eye. They may be administered topically into the eye or in a minimally invasive manner by periocular injection. Preferred liquid carriers are selected from semifluorinated alkanes.
申请公布号 US9241900(B2) 申请公布日期 2016.01.26
申请号 US201113884785 申请日期 2011.11.10
申请人 NOVALIQ GMBH 发明人 Wilson Clive G.
分类号 A61K9/00;A61K47/06;A61K9/08 主分类号 A61K9/00
代理机构 Hoxie & Associates LLC 代理人 Hoxie & Associates LLC
主权项 1. A method for treatment of a tissue associated with a posterior segment of an eye of a patient, comprising periocular injection of a pharmaceutical composition comprising an active ingredient and a non-aqueous, physiologically tolerable, liquid vehicle having a density of at least 1.2 g/ml, wherein the liquid vehicle comprises a semifluorinated alkane.
地址 Heidelberg DE